Marr, Kieren A. 2017. Infectious Diseases.
Hebbard, Andrew I.T. Slavin, Monica A. Reed, Caroline Teh, Benjamin W. Thursky, Karin A. Trubiano, Jason A. and Worth, Leon J. 2016. The epidemiology ofClostridium difficileinfection in patients with cancer. Expert Review of Anti-infective Therapy, Vol. 14, Issue. 11, p. 1077.
Zhang, Xuewu Chen, Yunbo Gu, Silan Zheng, Beiwen Lv, Tao Lou, Yinjun and Jin, Jie 2016. A case of multiple recurrence of Clostridium difficile infection with severe hematochezia in an immunocompromised host. Anaerobe, Vol. 42, p. 31.
Alonso, Carolyn D. and Kamboj, Mini 2014. Clostridium difficile Infection (CDI) in Solid Organ and Hematopoietic Stem Cell Transplant Recipients. Current Infectious Disease Reports, Vol. 16, Issue. 8,
Callejas-Díaz, Alejandro and Gea-Banacloche, Juan C. 2014. Clostridium difficile: Deleterious Impact on Hematopoietic Stem Cell Transplantation. Current Hematologic Malignancy Reports, Vol. 9, Issue. 1, p. 85.
Parmar, Sapna R Bhatt, Valkal Yang, Jie Zhang, Qiao and Schuster, Michael 2014. A retrospective review of metronidazole and vancomycin in the management of Clostridium difficile infection in patients with hematologic malignancies. Journal of Oncology Pharmacy Practice, Vol. 20, Issue. 3, p. 172.
Alonso, Carolyn D. and Marr, Kieren A. 2013. Clostridium difficile infection among hematopoietic stem cell transplant recipients. Current Opinion in Infectious Diseases, p. 1.
Vehreschild, M. J. G. T. Vehreschild, J. J. Hubel, K. Hentrich, M. Schmidt-Hieber, M. Christopeit, M. Maschmeyer, G. Schalk, E. Cornely, O. A. and Neumann, S. 2013. Diagnosis and management of gastrointestinal complications in adult cancer patients: evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Annals of Oncology, Vol. 24, Issue. 5, p. 1189.
Chang, K Kreuziger, L M B Angell, K Young, J-A and Ustun, C 2012. Recurrence of Clostridium difficile infection after total colectomy in an allogeneic stem cell transplant patient. Bone Marrow Transplantation, Vol. 47, Issue. 4, p. 610.
Collini, Paul J. Bauer, Martijn Kuijper, Ed and Dockrell, David H. 2012. Clostridium difficile infection in HIV-seropositive individuals and transplant recipients. Journal of Infection, Vol. 64, Issue. 2, p. 131.
Crook, D. W. Walker, A. S. Kean, Y. Weiss, K. Cornely, O. A. Miller, M. A. Esposito, R. Louie, T. J. Stoesser, N. E. Young, B. C. Angus, B. J. Gorbach, S. L. and Peto, T. E. A. 2012. Fidaxomicin Versus Vancomycin for Clostridium difficile Infection: Meta-analysis of Pivotal Randomized Controlled Trials. Clinical Infectious Diseases, Vol. 55, Issue. suppl 2, p. S93.
Dubberke, Erik R. Reske, Kimberlay A. Srivastava, Anand Sadhu, Justin Gatti, Robert Young, Rebecca M. Rakes, Lauren C. Dieckgraefe, Brian DiPersio, John and Fraser, Victoria J. 2010. Clostridium difficile-associated disease in allogeneic hematopoietic stem-cell transplant recipients: risk associations, protective associations, and outcomes. Clinical Transplantation, Vol. 24, Issue. 2, p. 192.
Khanna, Sahil and Pardi, Darrell S 2010. The growing incidence and severity ofClostridium difficileinfection in inpatient and outpatient settings. Expert Review of Gastroenterology & Hepatology, Vol. 4, Issue. 4, p. 409.
GUJJA, D. and FRIEDENBERG, F. K. 2009. Predictors of serious complications due toClostridium difficileinfection. Alimentary Pharmacology & Therapeutics, Vol. 29, Issue. 6, p. 635.
Henrich, Timothy J. Krakower, Douglas Bitton, Asaf and Yokoe, Deborah S. 2009. Clinical Risk Factors for SevereClostridium difficile–associated Disease. Emerging Infectious Diseases, Vol. 15, Issue. 3, p. 415.
Janka, Jacqueline and OʼGrady, Naomi P 2009. Clostridium difficile infection: current perspectives. Current Opinion in Critical Care, Vol. 15, Issue. 2, p. 149.
McFarland, Lynne V 2009. Renewed interest in a difficult disease: Clostridium difficile infections – epidemiology and current treatment strategies. Current Opinion in Gastroenterology, Vol. 25, Issue. 1, p. 24.
Belmares, Jaime Gerding, Dale N Tillotson, Glenn and Johnson, Stuart 2008. Measuring the severity ofClostridium difficileinfection: implications for management and drug development. Expert Review of Anti-infective Therapy, Vol. 6, Issue. 6, p. 897.
Dubberke, Erik R. Sadhu, Justin Gatti, Robert Reske, Kimberly A. DiPersio, John F. Devine, Steven M. and Fraser, Victoria J. 2008. Reply to Jaber et al. • . Infection Control and Hospital Epidemiology, Vol. 29, Issue. 2, p. 189.
Jaber, M. Raffat Reeves, Mark and Couperus, James 2008. Is Diarrhea Enough to Assess the Severity ofClostridium difficile–Associated Disease? • . Infection Control and Hospital Epidemiology, Vol. 29, Issue. 2, p. 187.
The purpose of this study was to develop and test a Clostridium difficile-associated disease (CDAD) grading system based on presenting symptoms in allogeneic stem cell transplant recipients. Patients with severe CDAD had significantly shorter median survival times and more adverse outcomes than patients with mild or moderate CDAD.
This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
Email your librarian or administrator to recommend adding this journal to your organisation's collection.
Abstract views reflect the number of visits to the article landing page.
* Views captured on Cambridge Core between September 2016 - 24th May 2017. This data will be updated every 24 hours.